Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome
Conditions: Psoriasis; Metabolic Syndrome Interventions: Drug: Secukinumab; Drug: Methotrexate Sponsor: Universita di Verona Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials